The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used intermittently, and a background of ichthyosis vulgaris.

In patients with chronic vulvar complaints, allergic contact dermatitis (ACD) shows high prevalence with 86.6% exhibiting positive patch test reactions, of which 37.9% were clinically relevant.

Adults with atopic dermatitis treated with upadacitinib had fewer major adverse cardiovascular events compared with background rates in real-world populations, adding to research supporting the ...

Photoallergic dermatitis, however, is an immune response that can cause rashes, inflammation, and pain following sun exposure, even where the exposure is minimal. 3. Photosensitivity: ...

Kymera Therapeutics, Inc. (NASDAQ:KYMR) on Monday revealed clinical results from the Phase 1 healthy volunteer study of KT-621, its first-in-class, oral STAT6 degrader medicine. The findings ...

Sun Pharma is also discontinuing studies of SCD-044 for atopic dermatitis after top-line results from a phase 2 clinical trial did not meet the primary objective of 75% improvement in EASI (Eczema ...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color. Dupixent achieved 75% or greater improvement in overall disease severity, the primary endpoint, in more ...

RAHWAY, N.J., May 30, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today safety and efficacy results from the open-label Phase 1 KANDLELIT-001 study, a ...

UNLOXCYT ™ can cause immune-mediated rash or dermatitis. Bullous and exfoliative dermatitis, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with ...

Soquelitinib Interim Data from the Atopic Dermatitis Phase 1 Clinical Trial As of May 28, 2025, enrollment in cohorts 1, 2 and 3 has been completed for a total of 48 patients and all patients ...